Binding of [3H]desglycinyl remacemide to rat brain membranes

Association with the benzomorphan attachment site of the N-methyl-D-aspartic acid receptor channel

Mahmoud Ahmed, A. Mather, S. J. Enna

Research output: Contribution to journalArticle

5 Citations (Scopus)

Abstract

Desglycinyl remacemide (DGR), a biologically active metabolite of remacemide, was radiolabeled in an attempt to develop a ligand binding assay to identify its site of action. Incubation of the radioligand with membranes obtained from P2 fractions of whole rat brain revealed a single population of specific [3H]-DGR binding sites having a K(d) of 290 nM and a B(max) of 1.3 pmole/mg protein. The specific binding of [3H]-DGR is most enriched in the P2 subcellular fraction and is heterogeneously distributed throughout the brain. The binding of [3H]-DGR to rat brain membranes was inhibited most potently by MK-801 and SKF-10,047. In contrast, haloperidol, and other sigma receptor-active agents, were relatively inactive at this site. These data suggest that DGR interacts with a channel blocking site on the NMDA receptor.

Original languageEnglish
Pages (from-to)46-50
Number of pages5
JournalBrain Research
Volume827
Issue number1-2
DOIs
StatePublished - May 8 1999
Externally publishedYes

Fingerprint

Benzomorphans
N-Methylaspartate
Membranes
Brain
sigma Receptors
Dizocilpine Maleate
Subcellular Fractions
Haloperidol
N-Methyl-D-Aspartate Receptors
aspartic acid receptor
remacemide
Binding Sites
Ligands

Keywords

  • Anticonvulsant
  • Desglycinyl remacemide
  • MK- 801
  • Phencyclidine
  • Remacemide
  • SKF-10,047

ASJC Scopus subject areas

  • Neuroscience(all)
  • Clinical Neurology
  • Developmental Biology
  • Molecular Biology

Cite this

Binding of [3H]desglycinyl remacemide to rat brain membranes : Association with the benzomorphan attachment site of the N-methyl-D-aspartic acid receptor channel. / Ahmed, Mahmoud; Mather, A.; Enna, S. J.

In: Brain Research, Vol. 827, No. 1-2, 08.05.1999, p. 46-50.

Research output: Contribution to journalArticle

@article{df269251956742cfa5e4b29221fa1d04,
title = "Binding of [3H]desglycinyl remacemide to rat brain membranes: Association with the benzomorphan attachment site of the N-methyl-D-aspartic acid receptor channel",
abstract = "Desglycinyl remacemide (DGR), a biologically active metabolite of remacemide, was radiolabeled in an attempt to develop a ligand binding assay to identify its site of action. Incubation of the radioligand with membranes obtained from P2 fractions of whole rat brain revealed a single population of specific [3H]-DGR binding sites having a K(d) of 290 nM and a B(max) of 1.3 pmole/mg protein. The specific binding of [3H]-DGR is most enriched in the P2 subcellular fraction and is heterogeneously distributed throughout the brain. The binding of [3H]-DGR to rat brain membranes was inhibited most potently by MK-801 and SKF-10,047. In contrast, haloperidol, and other sigma receptor-active agents, were relatively inactive at this site. These data suggest that DGR interacts with a channel blocking site on the NMDA receptor.",
keywords = "Anticonvulsant, Desglycinyl remacemide, MK- 801, Phencyclidine, Remacemide, SKF-10,047",
author = "Mahmoud Ahmed and A. Mather and Enna, {S. J.}",
year = "1999",
month = "5",
day = "8",
doi = "10.1016/S0006-8993(99)01263-9",
language = "English",
volume = "827",
pages = "46--50",
journal = "Brain Research",
issn = "0006-8993",
publisher = "Elsevier",
number = "1-2",

}

TY - JOUR

T1 - Binding of [3H]desglycinyl remacemide to rat brain membranes

T2 - Association with the benzomorphan attachment site of the N-methyl-D-aspartic acid receptor channel

AU - Ahmed, Mahmoud

AU - Mather, A.

AU - Enna, S. J.

PY - 1999/5/8

Y1 - 1999/5/8

N2 - Desglycinyl remacemide (DGR), a biologically active metabolite of remacemide, was radiolabeled in an attempt to develop a ligand binding assay to identify its site of action. Incubation of the radioligand with membranes obtained from P2 fractions of whole rat brain revealed a single population of specific [3H]-DGR binding sites having a K(d) of 290 nM and a B(max) of 1.3 pmole/mg protein. The specific binding of [3H]-DGR is most enriched in the P2 subcellular fraction and is heterogeneously distributed throughout the brain. The binding of [3H]-DGR to rat brain membranes was inhibited most potently by MK-801 and SKF-10,047. In contrast, haloperidol, and other sigma receptor-active agents, were relatively inactive at this site. These data suggest that DGR interacts with a channel blocking site on the NMDA receptor.

AB - Desglycinyl remacemide (DGR), a biologically active metabolite of remacemide, was radiolabeled in an attempt to develop a ligand binding assay to identify its site of action. Incubation of the radioligand with membranes obtained from P2 fractions of whole rat brain revealed a single population of specific [3H]-DGR binding sites having a K(d) of 290 nM and a B(max) of 1.3 pmole/mg protein. The specific binding of [3H]-DGR is most enriched in the P2 subcellular fraction and is heterogeneously distributed throughout the brain. The binding of [3H]-DGR to rat brain membranes was inhibited most potently by MK-801 and SKF-10,047. In contrast, haloperidol, and other sigma receptor-active agents, were relatively inactive at this site. These data suggest that DGR interacts with a channel blocking site on the NMDA receptor.

KW - Anticonvulsant

KW - Desglycinyl remacemide

KW - MK- 801

KW - Phencyclidine

KW - Remacemide

KW - SKF-10,047

UR - http://www.scopus.com/inward/record.url?scp=0033535631&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0033535631&partnerID=8YFLogxK

U2 - 10.1016/S0006-8993(99)01263-9

DO - 10.1016/S0006-8993(99)01263-9

M3 - Article

VL - 827

SP - 46

EP - 50

JO - Brain Research

JF - Brain Research

SN - 0006-8993

IS - 1-2

ER -